Project:Interface/Substance/Documentation: Difference between revisions
>PJosepherum mNo edit summary |
>PJosepherum mNo edit summary |
||
Line 1: | Line 1: | ||
{| width="100%" | |||
|- | |||
| colspan="2" style="width:100%; padding-bottom:10px; margin-bottom: 5px; border-bottom: 1px solid black; vertical-align:top; | | |||
I have drafted a solution below which describes a suitable data model for storing substance article content as semantic sub-objects which would be rendered using a master template for the published article, allowing modification of variables via form interfaces by contributors. | I have drafted a solution below which describes a suitable data model for storing substance article content as semantic sub-objects which would be rendered using a master template for the published article, allowing modification of variables via form interfaces by contributors. | ||
Left column is for cultural information, speculation, and other basic material. | Left column is for cultural information, speculation, and other basic material. Bottom Row is for semantic data collected from the trip reporter and presented as graphs, charts, and in tabular dorm. | ||
|- | |- | ||
| style="width:50%; padding-right:10px; margin-right:5px; border-right:1px solid black; vertical-align:top; | | | style="width:50%; padding-right:10px; margin-right:5px; border-right:1px solid black; vertical-align:top; | | ||
==Abstract== | ==Abstract== | ||
This is the introductory paragraph for the substance article, which should contain a summary of the information on this article for use in API calls and search results so that readers can quickly identify the substance. | This is the introductory paragraph for the substance article, which should contain a summary of the information on this article for use in API calls and search results so that readers can quickly identify the substance. | ||
Line 66: | Line 70: | ||
These sections will be used to discuss the physical and psychoactive consequences of administering the substance: | These sections will be used to discuss the physical and psychoactive consequences of administering the substance: | ||
==Pharmacodynamics== | |||
====Risk factors==== | ====Risk factors==== | ||
Line 74: | Line 78: | ||
* ''Indications for the therapeutic use of the substance'' | * ''Indications for the therapeutic use of the substance'' | ||
= | ====Pharmacokinetics=== | ||
===Pharmacokinetics=== | |||
* ''Receptor selectivity and affinities'' | * ''Receptor selectivity and affinities'' | ||
* ''Metabolism for various routes of administration and forms of substance'' | * ''Metabolism for various routes of administration and forms of substance'' | ||
* ''Statistics and descriptions of possible side effects'' | * ''Statistics and descriptions of possible side effects'' | ||
==Toxicity and harm potential== | |||
* ''Toxicity of substance'' | * ''Toxicity of substance'' | ||
* ''Dangerous drug interactions by co-administration of substances'' | * ''Dangerous drug interactions by co-administration of substances'' |